Du är här

2016-01-21

GLOBAL BIOENERGIES: Successful private placement of approximately €6.5 million by GLOBAL BIOENERGIES

Successful private placement of approximately €6.5 million by GLOBAL
BIOENERGIES

Evry, 21 January 2016
-

Global Bioenergies (Alternext Paris: ALGBE) (the "Company") today announces
the successful completion of a private placement with qualified French and
international investors. The Company placed 274,931
new shares at a par value of €0.05 per share, at a unit price of €23.70,
including share premium, for a total of approximately €6.5 million amounting
to 9.6% of the Company's share capital

For information, the stake of a shareholder with 1% of the Company's share
capital prior to the issue will be brought to 0.91%.

The proceeds will be used to further the development of the Isobutene process
and to launch commercial roll-out. Marc Delcourt, CEO at Global Bioenergies
says: "The success of this transaction demonstrates investors' confidence in
our corporate strategy. The proceeds of the placement increase the Company's
unaudited cash to 16.5 million euros. They will enable the Company to fully
transition into the commercial phase ".

The principle of the capital raising was authorized on 5 January 2016. The
transaction was carried out pursuant to a Board decisions dated 20 January
2016 and 21 January 2016, in accordance with the authority granted to it by
the eighth resolution of the Combined General Meeting of Shareholders on 3
June 2015. The subscription price represented a discount of 14.1% over the
volume weighted average Company's share price in the last three trading
sessions prior to the issue.

The capital increase is by means of the issue of common shares without
preferential subscription rights to qualified investors, in accordance with
Article L. 411-2 II of the French Monetary and Financial Code (Code monétaire
et financier). The new shares will carry entitlement to dividend rights and
will be admitted to trading on the Euronext Paris Alternext market under ISIN
code FR0011052257 - ALGBE. On settlement and delivery of the shares,
Company's share capital will comprise 3,145,128 shares.

The Private Placement is conducted by Gilbert Dupont (Paris) and Baader Bank
AG (Munich) as joint lead managers and joint bookrunners. The issue does not
require registration with the French financial markets authority (AMF) or
publication of a prospectus.

Legal notice

Securities may not be offered or sold in the United States unless they have
been registered pursuant to the 1993 U.S. Securities Act de 1933, as amended
("U.S. Securities Act"), or are exempt from the registration requirements of
the U.S. Securities Act. The Company's securities covered by this press
release have not been and will not be registered under the U.S. Securities
Act, and the Company does not intend to issue a public offering of the
securities which are the subject of this press release in the United States.
About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in
Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its efforts
on the production of isobutene, one of the most important petrochemical
building blocks that can be converted into fuels, plastics, organic glass and
elastomers. Global Bioenergies continues to improve the performances of its
process, operates its industrial pilot, has begun the construction of its
demo plant in Germany, and is preparing the first full-scale plant through a
joint venture with Cristal Union, named IBN-One. The company also replicated
its achievement to propylene and butadiene, two members of the gaseous
olefins family, key molecules at the heart of petrochemical industry. Global
Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE) and
on the Alternext Oseo Innovation index.

Should you like to be kept informed, subscribe to our
news feed on www.global-bioenergies.com

Follow us on Twitter:
@GlobalBioenergi

Contact

GLOBAL BIOENERGIES

François-Henri Sahakian
Chief Financial Officer
Phone: +33 (0)1 64 98 20 50
Email:invest@global-bioenergies.com

----
| |
| |
----
Press release
http://hugin.info/166909/R/1980358/725465.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBAL BIOENERGIES via Globenewswire

HUG#1980358

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.